Audit Committee
Mr P. R. Ramesh graduated in Commerce from Osmania University, Hyderabad and is a Fellow Member of the ICAI. He retired as the Director of Deloitte & Touche Assurance & Enterprise Risk Services India on 31st March 2020 and has also served as a member of Deloitte Global Board and Deloitte Asia Pacific Board. Ramesh has over 40 years of professional experience across manufacturing, banking and financial services, technology, media, telecommunications, energy and resources and consumer business sectors. He has been associated with various Regulatory bodies such as SEBI Committee on Disclosures and Accounting Standards; Committee for Reforming the Regulatory Environment for doing Business in India; Technical Committee to review the form and presentation of the Balance Sheet of the RBI; IRDA Standing Committee on Accounting Issues and Invitee to the Committee set up by the RBI to assist in convergence to IFRS by banks and National Advisory Committee on Accounting Standards. He has been associated with various Industry Bodies such as CII representing on its National Council, Committee on Financial Reporting and its CFO Forum; National Executive Committee of FICCI and Past President of the of the Bombay Chamber of Commerce & Industry. He has also been member of Accounting Standards Board of ICAI, Vision and Restructuring Committee and Auditing Practices Committee of ICAI and the Secretarial Standards Boards of the ICSI. He has co-authored publication by CCH titled iGAAP – Financial Reporting Standards in India including a comparison with IFRS and is a member of Board of Studies and the Faculty of Commerce of Osmania University.
Sharmila brings over 30 years of IT industry experience, with more than 25 years spent at Wipro, where she held leadership positions like Country Head for the UK and Global Head of Industrial Manufacturing. She has extensive global expertise in strategy, sales, business development, and program management across various industries. She has successfully led large-scale organizational changes and spearheaded significant business growth and transformation projects.
Sharmila presently also serves as an Executive Director on the Board of Doorstep School Foundation, an NGO focusing on Fundamental Literacy and Numeracy. Sharmila has also shown strong commitment to employee well-being through her roles as Chief Ombudsperson and Chair of the Prevention of Sexual Harassment Committee at Wipro.
Dr. Balram Bhargava is a global public health leader. Mission driven, results oriented health professional with more than 35 years of experience in leading medical research, strengthening health systems, health care innovation, managing pandemic preparedness and health care delivery in resource poor settings. As a global leader he has been in the forefront of south-south cooperation, promoting equity in access to health care, democratisation of scientific research and promoting public-private cooperation to bring new technologies and affordable innovative products into the health systems.
He has led India’s Department of Health Research as its Secretary and Director-General of the Indian Council of Medical Research. He is also a Professor of Cardiology at the All-India Institute of Medical Sciences, New Delhi and serves as the Executive Director for Stanford India Biodesign Centre, School of International Biodesign (SiB). An extensively published scientist with more than 300 articles in peer reviewed journals and editor-in-chief of the British Medical Journal Innovations and of the Indian Journal of Medical Research.
His experience ranges from treating more than a quarter million patients, training and mentoring super specialised cardiologists to setting health care policies and standards and advising several Ministers of Health and Heads of Government. In recent years he has been at the forefront of managing several public health crises in India including covid-19 and brought Indian research in shaping contemporary global practice through vaccine development and describing role of plasma therapy. He has also received numerous international and national awards for his contributions to health and development and has delivered more than 50 orations across the globe. He has international experience of more than 6 years in the USA, Europe and the Middle East.
Nomination and Remuneration Committee
Mandar spent 15 years at McKinsey (2002-2017), the last seven as partner where he co-led the healthcare practice in India and established the Hospitals practice for Asia. He served leading pharmaceutical companies across India and globally across several areas such as core strategy, manufacturing productivity improvement, R&D productivity, portfolio management, M&A and procurement programs.
From 2017 to 2019 Mandar worked part time advising several healthcare companies, providing leadership coaching and designing and teaching a course on problem solving at Ashoka University.
In Aug 2019, Mandar joined global travel-tech company OYO as CEO – SE Asia & Middle East, driving growth, doubling the number of hotels and homes, while transforming the regions contribution margin to a net positive territory. He led the business through the COVID crisis, improving EBIDTA loss to a negligible level while manging massive business disruptions.
Since March 2021 Mandar is the CEO - OYO Vacation Homes (OVH), Europe, a strategically important core market for the company. OVH is Europe's second largest vacation homes company. Mandar leads three acquired brands, DanCenter, Belvilla and Traum FW, each with a multi decade legacy. He has turbo charged their growth and profitability by migrating them into a tech forward environment while retaining the uniqueness of each businesses bult over the last several decades.
Mandar grew up in Mumbai, but now lives in Gurgaon with his wife and 3-year-old son. He enjoys spending time with his friends, watching movies, and trying out his hand at new pursuits, especially outdoors.
Mr Adil Zainulbhai is a Mechanical Engineering graduate from the Indian Institute of Technology and an MBA from Harvard Business School. Mr Zainulbhai retired as Chairman of McKinsey, India after a distinguished 34-year career with the firm, including leadership roles in its Washington and Minneapolis offices. His influence extends beyond McKinsey, serving as Chairman of the Quality Council of India and as a Board Advisor to the US India Strategic Partnership Forum. He has been a director on the boards of prominent corporates in India like Larsen and Tourbo, Reliance Industries etc. and is the Chairman on the Boards of Network 18 Media and Investments Limited and TV18 Broadcast Limited. He has also been on the international advisory boards of various international organisations and a member of various high powered economic groups, advisory committees and task forces of Government of India.
Robert Stewart is an Independent Non-Executive Director of the Company.
He has over 34 years of experience in the biopharmaceutical industry having worked with leading companies such as Roche, Abbott, Watson / Actavis / Allergan, Amneal and Theramex. Currently, Robert is the Chief Executive Officer at Theramex Ltd, a global specialty pharmaceutical company.
Robert has deep expertise in manufacturing operations, quality, supply chain and general management and a very strong exposure to commercial operations. He has served on the boards of several industry and non-profit organizations and served for nearly two years on the Amneal board of directors.
Robert has a B.S., Business Management from Fairleigh Dickinson University, New Jersey
Sharmila brings over 30 years of IT industry experience, with more than 25 years spent at Wipro, where she held leadership positions like Country Head for the UK and Global Head of Industrial Manufacturing. She has extensive global expertise in strategy, sales, business development, and program management across various industries. She has successfully led large-scale organizational changes and spearheaded significant business growth and transformation projects.
Sharmila presently also serves as an Executive Director on the Board of Doorstep School Foundation, an NGO focusing on Fundamental Literacy and Numeracy. Sharmila has also shown strong commitment to employee well-being through her roles as Chief Ombudsperson and Chair of the Prevention of Sexual Harassment Committee at Wipro.
Ms Punita Lal is an Independent Non-Executive Director of the Company. She has 30 years of experience in strategy, marketing and leadership in the corporate world across Asia, spanning multiple disciplines, geographies and cultures. Ms Lal has a BA(Hons) in Economics from St Stephen’s College, Delhi and an MBA from the Indian Institute of Management, Kolkata.
As a senior business leader, she has many accolades to her credit, including being chosen as one of India’s top 20 Businesswomen by Business Today in 2006, and being awarded Corporate Woman of the Year in 2009 by the FICCI Women’s Organisation. She is currently practising as an Independent Strategy and Marketing Consultant.
Corporate Social Responsibility Committee
Stakeholders Relationship Committee
Dr. Mandar is a medical doctor, and a management graduate from the Jamnalal Bajaj Institute of Management Studies, India.
Mandar spent 15 years at McKinsey (2002-2017), the last seven as partner where he co-led the healthcare practice in India and established the Hospitals practice for Asia. He served leading pharmaceutical companies across India and globally across several areas such as core strategy, manufacturing productivity improvement, R&D productivity, portfolio management, M&A and procurement programs.
From 2017 to 2019 Mandar worked part time advising several healthcare companies, providing leadership coaching and designing and teaching a course on problem solving at Ashoka University.
In Aug 2019, Mandar joined global travel-tech company OYO as CEO – SE Asia & Middle East, driving growth, doubling the number of hotels and homes, while transforming the regions contribution margin to a net positive territory. He led the business through the COVID crisis, improving EBIDTA loss to a negligible level while manging massive business disruptions.
Since March 2021 Mandar is the CEO - OYO Vacation Homes (OVH), Europe, a strategically important core market for the company. OVH is Europe's second largest vacation homes company. Mandar leads three acquired brands, DanCenter, Belvilla and Traum FW, each with a multi decade legacy. He has turbo charged their growth and profitability by migrating them into a tech forward environment while retaining the uniqueness of each businesses bult over the last several decades.
Mandar grew up in Mumbai, but now lives in Gurgaon with his wife and 3-year-old son. He enjoys spending time with his friends, watching movies, and trying out his hand at new pursuits, especially outdoors.
Mr Adil Zainulbhai is a Mechanical Engineering graduate from the Indian Institute of Technology and an MBA from Harvard Business School. Mr Zainulbhai retired as Chairman of McKinsey, India after a distinguished 34-year career with the firm, including leadership roles in its Washington and Minneapolis offices. His influence extends beyond McKinsey, serving as Chairman of the Quality Council of India and as a Board Advisor to the US India Strategic Partnership Forum. He has been a director on the boards of prominent corporates in India like Larsen and Tourbo, Reliance Industries etc. and is the Chairman on the Boards of Network 18 Media and Investments Limited and TV18 Broadcast Limited. He has also been on the international advisory boards of various international organisations and a member of various high powered economic groups, advisory committees and task forces of Government of India.
Dr. Balram Bhargava is a global public health leader. Mission driven, results oriented health professional with more than 35 years of experience in leading medical research, strengthening health systems, health care innovation, managing pandemic preparedness and health care delivery in resource poor settings. As a global leader he has been in the forefront of south-south cooperation, promoting equity in access to health care, democratisation of scientific research and promoting public-private cooperation to bring new technologies and affordable innovative products into the health systems.
He has led India’s Department of Health Research as its Secretary and Director-General of the Indian Council of Medical Research. He is also a Professor of Cardiology at the All-India Institute of Medical Sciences, New Delhi and serves as the Executive Director for Stanford India Biodesign Centre, School of International Biodesign (SiB). An extensively published scientist with more than 300 articles in peer reviewed journals and editor-in-chief of the British Medical Journal Innovations and of the Indian Journal of Medical Research.
His experience ranges from treating more than a quarter million patients, training and mentoring super specialised cardiologists to setting health care policies and standards and advising several Ministers of Health and Heads of Government. In recent years he has been at the forefront of managing several public health crises in India including covid-19 and brought Indian research in shaping contemporary global practice through vaccine development and describing role of plasma therapy. He has also received numerous international and national awards for his contributions to health and development and has delivered more than 50 orations across the globe. He has international experience of more than 6 years in the USA, Europe and the Middle East.
Investment And Risk Management Committee
Robert Stewart is an Independent Non-Executive Director of the Company.
He has over 34 years of experience in the biopharmaceutical industry having worked with leading companies such as Roche, Abbott, Watson / Actavis / Allergan, Amneal and Theramex. Currently, Robert is the Chief Executive Officer at Theramex Ltd, a global specialty pharmaceutical company.
Robert has deep expertise in manufacturing operations, quality, supply chain and general management and a very strong exposure to commercial operations. He has served on the boards of several industry and non-profit organizations and served for nearly two years on the Amneal board of directors.
Robert has a B.S., Business Management from Fairleigh Dickinson University, New Jersey.
Mr Abhijit Joshi is the Founding and Managing Partner of a leading law firm M/s Veritas Legal, in India and has over 35 years of experience and expertise in the field of corporate and commercial law, merger & acquisition, risk management, litigation management etc. He is a distinguished dual-qualified solicitor in both India and England. With a legal career spanning over three decades, he is recognized as one of Asia’s Top 15 M&A and Private Wealth Lawyers. Mr Joshi has advised numerous business houses and promoter families, representing global conglomerates and large private equity firms in a wide range of complex deals and cases across various industry sectors, including the pharmaceutical industry. Mr Joshi also possesses skills in global economics, financials, risk management, strategic planning, corporate governance etc. His skills and expertise have earned him several accolades, including the Financial Times Innovation Award (Asia Pacific).
Ms Samina Hamied is the Executive Vice-Chairperson of the Company, and represents the third generation of Cipla’s founding family. Samina is a MSc in International Accounting and Finance from the London School of Economics and Political Science. An alumna of the London School of Economics, she has in the past worked in UK and the US with the leading global firm Goldman Sachs before joining the Cipla leadership team in 2011. Samina joined Cipla in the year 2011 as a member of management team. In the year 2013, she was designated as the “Head Strategic Projects – Cipla New Ventures”. She was appointed as an Executive Director of the Company w.e.f. 10th July, 2015 and subsequently she was elevated as the Executive Vice-Chairperson of the Company, w.e.f. 1st September, 2016. She has been instrumental in driving the Company’s current transformation agenda. Samina played a key role in successfully incubating and shaping Cipla Health Limited, spearheaded Cipla’s ambitious foray into the US market with strategic acquisitions. Samina has built a top-class leadership pipeline for the Company as it continues to spread its wings globally. As Executive Vice-Chairperson of Cipla, Samina focuses on board and governance issues, in addition to furthering Cipla’s strategic priorities through key global partnerships, corporate culture, hiring the right talent, and public advocacy. Recognised as the promoter face of Cipla, Samina has been feted for her diverse work experience and business knowledge. In 2017, she received the ‘Most Powerful Women in Business’ award from Business Today. In 2018, Forbes named Samina among the top 25 emergent women business leaders in Asia, and Fortune India named her among the most powerful women in business
Mr Umang Vohra joined Cipla in 2015, and has been Managing Director and Global Chief Executive Officer of Cipla since September 2016. After gaining degrees in engineering, marketing and finance, Umang worked with Eicher Motors, PepsiCo and Dr Reddy’s. Through his previous roles in India and the US, he has built a distinguished career spanning almost two decades with deep understanding and experience in various aspects of the global pharmaceutical business. As Cipla’s MD & GCEO, Umang’s priorities have been Cipla’s strategic growth, defining and executing Cipla’s roadmap to maintain momentum in home markets whilst strengthening its presence in other regions, consolidating its core focus areas, augmenting capability, and building the right organisation. Recognised as an action-oriented industry leader, Umang is a firm believer in the power of agile business models, disruptive technologies, data-driven analytics and a future-ready workforce with a view to making a difference to the lives of patients.
Mr P. R. Ramesh graduated in Commerce from Osmania University, Hyderabad and is a Fellow Member of the ICAI. He retired as the Director of Deloitte & Touche Assurance & Enterprise Risk Services India on 31st March 2020 and has also served as a member of Deloitte Global Board and Deloitte Asia Pacific Board. Ramesh has over 40 years of professional experience across manufacturing, banking and financial services, technology, media, telecommunications, energy and resources and consumer business sectors. He has been associated with various Regulatory bodies such as SEBI Committee on Disclosures and Accounting Standards; Committee for Reforming the Regulatory Environment for doing Business in India; Technical Committee to review the form and presentation of the Balance Sheet of the RBI; IRDA Standing Committee on Accounting Issues and Invitee to the Committee set up by the RBI to assist in convergence to IFRS by banks and National Advisory Committee on Accounting Standards. He has been associated with various Industry Bodies such as CII representing on its National Council, Committee on Financial Reporting and its CFO Forum; National Executive Committee of FICCI and Past President of the of the Bombay Chamber of Commerce & Industry. He has also been member of Accounting Standards Board of ICAI, Vision and Restructuring Committee and Auditing Practices Committee of ICAI and the Secretarial Standards Boards of the ICSI. He has co-authored publication by CCH titled iGAAP – Financial Reporting Standards in India including a comparison with IFRS and is a member of Board of Studies and the Faculty of Commerce of Osmania University.
Operations And Administrative Committee
Mr Umang Vohra joined Cipla in 2015, and has been Managing Director and Global Chief Executive Officer of Cipla since September 2016. After gaining degrees in engineering, marketing and finance, Umang worked with Eicher Motors, PepsiCo and Dr Reddy’s. Through his previous roles in India and the US, he has built a distinguished career spanning almost two decades with deep understanding and experience in various aspects of the global pharmaceutical business. As Cipla’s MD & GCEO, Umang’s priorities have been Cipla’s strategic growth, defining and executing Cipla’s roadmap to maintain momentum in home markets whilst strengthening its presence in other regions, consolidating its core focus areas, augmenting capability, and building the right organisation. Recognised as an action-oriented industry leader, Umang is a firm believer in the power of agile business models, disruptive technologies, data-driven analytics and a future-ready workforce with a view to making a difference to the lives of patients.
Mr Adil Zainulbhai is a Mechanical Engineering graduate from the Indian Institute of Technology and an MBA from Harvard Business School. Mr Zainulbhai retired as Chairman of McKinsey, India after a distinguished 34-year career with the firm, including leadership roles in its Washington and Minneapolis offices. His influence extends beyond McKinsey, serving as Chairman of the Quality Council of India and as a Board Advisor to the US India Strategic Partnership Forum. He has been a director on the boards of prominent corporates in India like Larsen and Tourbo, Reliance Industries etc. and is the Chairman on the Boards of Network 18 Media and Investments Limited and TV18 Broadcast Limited. He has also been on the international advisory boards of various international organisations and a member of various high powered economic groups, advisory committees and task forces of Government of India.